SCHEMBL6155641

SCHEMBL6155641

CCOC(=O)N1CCC2(CC1)c1ccccc1CS2(=O)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.52
APP P05067 7/20 0.49
L3MBTL1 Q9Y468 2/20 0.45
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
SLC22A1 O15245 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155020 0.87 AVPR1A (0.51) AVPR1ATSHRALDH1A1MEN1KMT2A
SCHEMBL6153716 0.87 KDM1A (0.50) AVPR1AL3MBTL1SMN1; SMN2SLC6A4OPRD1
SCHEMBL6155331 0.84 AVPR1A (0.48) AVPR1ATSHR
SCHEMBL9965972 0.79 AVPR1A (0.48) AVPR1ASMN1; SMN2TSHROPRM1
SCHEMBL6154922 0.77 AVPR1A (0.51) AVPR1ATSHR
SCHEMBL11831680 0.73 AVPR1A (0.60) AVPR1AAPP
SCHEMBL6153677 0.73 APP (0.50) APPL3MBTL1PSEN1PSEN2APH1B
SCHEMBL9963297 0.73 AVPR1A (0.44) AVPR1ASMN1; SMN2OPRM1OPRD1OPRK1
SCHEMBL6247508 0.72 APP (0.60) APPL3MBTL1PSEN1PSEN2APH1B
SCHEMBL1295044 0.72 ALDH1A1 (0.64) L3MBTL1LMNAGAASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209262-A1 Process for producing optically active sulfoxide SANKYO COMPANY, LIMITED (JP) 2005-09-22 US disclosed
EP-1557420-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE SULFOXIDE Sankyo Company, Limited (JP) 2005-07-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209262-A1 Process for producing optically active sulfoxide TST, TMT1A, PPOX AVPR1A 3530/4885APP 1937/4885L3MBTL1 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.